← Leaderboards
Danny Hung-Chieh Chou
University Of Utah
$8,295,834
Attributed
$8,295,834
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,295,834 · 4
By mechanism
R01$4,723,865 · 2
R35$2,027,203 · 1
DP1$1,544,766 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Christopher P. Hill$27,112,994
- Helena Safavi-Hemami$1,861,171
Others in their field
Other Emerging Leaders on “Insulin”
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Michael P Harms · Washington University$13,645,932
- Noel P Burtt · Broad Institute, Inc.$10,557,791
- David N. Wholley · Foundation For The Nih$10,394,136
- Pradeep Natarajan · Massachusetts General Hospital$9,417,826
Research focus
InsulinAnalogIn VivoLeadInsulin ReceptorLearningDiabetes MellitusCellsGlycemic ControlDesignBindingHypoglycemiaGlucosePharmaceutical ChemistryPropertyFda ApprovedExcipientsFormulationCessation Of LifeEffectivenessBlood GlucoseBlood Glucose RegulationDangerousnessSeries
Grant awards (17)
Beyond insulin: Next-generation modulators of insulin receptor for glycemic control$772,383
DP1 · FY2025 · DK · contact PI
Beyond insulin: Next-generation modulators of insulin receptor for glycemic control$772,383
DP1 · FY2024 · DK · contact PI
Development of long-acting glucose-responsive insulin formulations$627,795
R01 · FY2023 · DK · contact PI
Development of long-acting glucose-responsive insulin formulations$639,211
R01 · FY2022 · DK · contact PI
Development of long-acting glucose-responsive insulin formulations$623,959
R01 · FY2021 · DK · contact PI
DEVELOPMENT OF CONCENTRATED, STABLE ULTRA FAST-ACTING INSULIN FORMULATION$545,343
R01 · FY2021 · DK · contact PI
STUDIES ON INSULIN RECEPTOR ISO FORMS$387,956
R35 · FY2021 · GM · contact PI
STUDIES ON INSULIN RECEPTOR ISO FORMS$135,128
R35 · FY2021 · GM · contact PI
Development of long-acting glucose-responsive insulin formulations$643,846
R01 · FY2020 · DK · contact PI
DEVELOPMENT OF CONCENTRATED, STABLE ULTRA FAST-ACTING INSULIN FORMULATION$559,768
R01 · FY2020 · DK · contact PI
STUDIES ON INSULIN RECEPTOR ISO FORMS$387,254
R35 · FY2020 · GM · contact PI
Development of concentrated, stable ultra fast-acting insulin formulation$535,409
R01 · FY2019 · DK · contact PI
Studies on insulin receptor ISO forms$191,548
R35 · FY2019 · GM · contact PI
STUDIES ON INSULIN RECEPTOR ISO FORMS$175,233
R35 · FY2019 · GM · contact PI
Development of concentrated, stable ultra fast-acting insulin formulation$548,534
R01 · FY2018 · DK · contact PI
Studies on insulin receptor ISO forms$381,250
R35 · FY2018 · GM · contact PI
Studies on insulin receptor ISO forms$368,834
R35 · FY2017 · GM · contact PI